Ziyad Al-Aly
Ziyad Al-Aly is a clinical epidemiologist at Washington University in St. Louis. He specializes in studying the health effects of medications and chronic diseases. Recently, he commented on a small study that suggested potential vision problems associated with GLP-1 receptor agonists, emphasizing the need for larger, controlled studies to better understand the implications and risks of these widely used diabetes and weight-loss drugs.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Argentina:
Ziyad Al-Aly is a clinical epidemiologist at Washington University in St. Louis who commented on the study's findings.
7
Honduras:
Ziyad Al-Aly is a senior clinical epidemiologist at the University of Washington in St. Louis, Missouri.
7
Liechtenstein:
Ziyad Al-Aly is the senior author of the study examining the effects of GLP-1 analogs.
8
India:
Dr. Ziyad Al-Aly is the chief of research and development at the VA St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis.
8
United States:
Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis, was not involved in the study but shared his comments on the findings.
5